Spondyloarthritis and Crohn’s disease in an adolescent
DOI:
https://doi.org/10.32385/rpmgf.v40i5.13970Keywords:
Spondyloarthritis, Crohn's disease, AdalimumabAbstract
Introduction: This case report follows an adolescent female with articular and bowel symptoms, highlighting the association between spondyloarthritis and Crohn’s disease.
Case description: The first symptoms were joint pain, mainly in the knee and lower back leading to a possible autoimmune disease diagnosis, supported by elevation of inflammatory markers and magnetic resonance imaging showing sacroilitis. After that, the patient developed diarrhea and rectal bleeding, with colonoscopy revealing pancolitis and ulcerations. Main diagnosis, therapeutics, and results: The initial evaluation by a rheumatology specialist suggested spondyloarthritis or juvenile idiopathic arthritis as differential diagnosis establishing treatment with non-steroidal anti-inflammatory drugs and prednisolone. Cooperation with gastroenterology led to the diagnosis of spondyloarthritis associated with Crohn’s disease, changing the medication to adalimumab.
Comment: This clinical case report highlights the importance of interdisciplinary cooperation when managing complex diagnoses and establishing suitable therapeutical strategies in autoimmune diseases. This case reinforces the role of the family doctor as a patient manager and as a key element in the acceptance of chronic illness by the patient and their family.
Downloads
References
1. Karreman MC, Luime JJ, Hazes JM, Weel AE. The prevalence and incidence of axial and peripheral spondyloarthritis in inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis. 2017;11(5):631-42.
2. Ranasinghe IR, Tian C, Hsu R. Crohn disease [Internet]. Treasure Island: StatPearls Publishing; 2023 Jan [updated 2024 Feb]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK436021/
3. Ossum AM, Palm Ø, Lunder AK, Cvancarova M, Banitalebi H, Negård A, et al. Ankylosing spondylitis and axial spondyloarthritis in patients with long-term inflammatory bowel disease: results from 20 years of follow-up in the IBSEN study. J Crohns Colitis. 2018;12(1):96-104.
4. Lim CS, Tremelling M, Hamilton L, Kim M, Macgregor A, Turmezei T, et al. Prevalence of undiagnosed axial spondyloarthritis in inflammatory bowel disease patients with chronic back pain: secondary care cross-sectional study. Rheumatology (Oxford). 2023;62(4):1511-8.
5. Danve A, Deodhar A. Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities. Clin Rheumatol. 2019;38(3):625-34.
6. Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ. Long-term complications, extraintestinal manifestations, and mortality in adult Crohn’s disease in population-based cohorts. Inflamm Bowel Dis. 2011;17(1):471-8.
7. Tromm A, May D, Almus E, Voigt E, Greving I, Schwegler U, et al. Cutaneous manifestations in inflammatory bowel disease. Z Gastroenterol. 2001;39(2):137-44.
8. Abdesslem NB, Mahjoub A, Sayadi S, Zbiba W. Ocular manifestations of Crohn’s disease. Tunis Med. 2019;97(5):692-7.
9. Youssef J, Novosad SA, Winthrop KL. Infection risk and safety of corticosteroid use. Rheum Dis Clin North Am. 2016;42(1):157-76.
10. Mokhtare M, Valizadeh SM, Emadian O. Lower gastrointestinal bleeding due to non-steroid anti-inflammatory drug-induced colopathy case report and literature review. Middle East J Dig Dis. 2013;5(2):107-11.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Portuguese Journal of Family Medicine and General Practice

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.